COX-2 Inhibition in Esophagitis, Barrett's Esophagus and Esophageal Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|27|2267-2280

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.27, 2003-10, pp. : 2267-2280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer and Cyclooxygenase-2 (COX-2) Inhibition

By  

Current Pharmaceutical Design, Vol. 10, Iss. 6, 2004-02 ,pp. : 627-634

Bentham Science Publishers

Access to resources Recommend Favorite

Endoscopic therapy in early adenocarcinomas (Barrett's cancer) of the esophagus

By  

Journal of Digestive Diseases, Vol. 16, Iss. 7, 2015-07 ,pp. : 363-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

COX-2 inhibition has potential for lung cancer prevention

By  

Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

COX-2 inhibition in cancer therapeutics: a field of controversy or a magic bullet?

By Karamouzis Michalis V   Papavassiliou Athanasios G  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 359-372

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms of Colon Cancer Prevention with and Beyond COX-2 Inhibition

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 5, 2005-01 ,pp. : 505-516

Bentham Science Publishers

Access to resources Recommend Favorite